Karuna therapeutics, inc. (KRTX)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Dec'18
Assets
Current assets:
Cash and cash equivalents

190,645

208,929

54,144

10,495

8,904

Short-term investments

192,846

180,468

107,461

64,804

4,983

Deferred offering costs

-

-

-

2,032

-

Prepaid expenses and other current assets

3,177

3,309

2,323

1,717

1,709

Total current assets

386,668

392,706

163,928

79,048

15,596

Restricted cash

157

123

123

123

123

Property and equipment, net

371

195

176

186

138

Right-of-use lease assets - operating, net

2,522

-

-

-

-

Total assets

389,718

393,024

164,227

79,357

15,857

Liabilities and Stockholders’ Equity (Deficit)
Current liabilities:
Accounts payable (includes $0 and $51 at March 31, 2020 and December 31, 2019, respectively, due to related parties)

603

547

158

960

269

Accrued expenses

1,425

2,353

1,319

1,260

538

Current portion of deferred lease obligation

-

58

56

55

-

Current portion of operating lease liability

624

-

-

-

-

Derivative liability

-

-

-

-

389

Derivative liability

-

-

0

-

-

Total current liabilities

2,652

2,958

1,533

2,275

1,196

Non-current convertible notes, net of discount

-

-

-

-

2,516

Deferred lease obligation, net of current portion

-

150

164

179

102

Operating lease liability, net of current portion

2,125

-

-

-

-

Total liabilities

4,777

3,108

1,697

2,454

3,814

Redeemable convertible preferred stock, (Series Seed, A and B) $0.0001 par value; 0 and 7,539,200 shares authorized and outstanding at December 31, 2019 and 2018, respectively

-

-

-

-

41,965

Stockholders’ equity:
Common stock, $0.0001 par value; 150,000,000 shares authorized at March 31, 2020 and December 31, 2019; 26,094,892 and 26,012,754 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively

3

3

2

-

-

Additional paid-in capital

467,537

465,420

230,216

11,640

1,633

Accumulated deficit

-84,170

-75,512

-67,738

-58,700

-31,555

Accumulated other comprehensive income

1,571

5

-

-

-

Accumulated other comprehensive income

-

-

50

71

-

Total stockholders’ equity

384,941

389,916

162,530

-46,989

-29,922

Total liabilities, redeemable convertible preferred stock and stockholders’ equity

389,718

393,024

164,227

79,357

15,857

Series Seed Redeemable Convertible Preferred Stock
Redeemable convertible preferred stock

-

-

-

1

-

Series A Redeemable Convertible Preferred Stock
Redeemable convertible preferred stock

-

-

-

41,964

-

Series B Redeemable Convertible Preferred Stock
Redeemable convertible preferred stock

-

-

-

81,927

-